Based on these features, it is demonstrated in mice with fatty liver that the bioinspired‐responsive microneedles can facilitate prolactin mitigating hepatic steatosis through its interaction with the hepatic prolactin receptor (PRLR) and by modulating the expression of fatty acid translocase (FAT/CD36). The gene discussed is CD36; the disease is fatty liver disease.